Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Find generic entry opportunities
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Abstract:||A method of crosslinking a crosslinkable protein or carbohydrate substrate to form a crosslinked substrate in which the crosslinking groups are biodegradable. The crosslinking groups may comprise methylene diacrylate and the substrate can be galactose.|
|Inventor(s):||Klaveness; Jo (Oslo, NO), Rongved; P.ang.l (Nesoddtangen, NO), Strande; Per (Oslo, NO)|
|Assignee:||Nycomed Imaging AS (Oslo, NO)|
|Filing Date:||Jun 02, 1995|
|Claims:||1. A method of crosslinking a crosslinkable protein or carbohydrate substrate to form a crosslinked substrate in which the crosslinking groups are biodegradable, said method comprising reacting said crosslinkable substrate with a crosslinking agent of formula (IIIa) ##STR13## wherein Q is selected from the group consisting of halogen atoms, alkanesulphonyloxy groups, arenesulphonyloxy groups and groups of formula --O.CO.(O).sub.n.R.sup.9.B; |
m and n may be the same or different and are each selected from the group consisting of zero and 1;
R.sup.1 and R.sup.2 may be the same or different and are each selected from the group consisting of hydrogen atoms, aliphatic, cycloalkyl, araliphatic, aryl and heterocyclic groups, groups of formula --O.CO.(O).sub.m.R.sup.8.A and groups of formula --O.CO.(O).sub.n.R.sup.9.B, or R.sup.1 and R.sup.2 together form an alkylene, alkenylene, alkylidene or alkenylidene group;
R.sup.8 and any group R.sup.9 may be the same or different and are each selected from the group consisting of alkylene groups; alkenylene groups; phenyleneethynylmethylene; cycloalkylene groups; arylene groups; C.sub.1-6 alkyl substituted arylene groups; aralkylene groups; C.sub.1-6 alkyl substituted aralkylene groups; heterocyclic groups; any of the foregoing substituted by one or more of oxo, thio, hydroxyl, etherified hydroxyl, esterified hydroxyl, etherified thiol, N--(C.sub.1-6 alkyl) amino, N--(C.sub.1-6 acyl) amino, N--(C.sub.1-6 acyl) --N--(C.sub.1-6 alkyl) amino, carbamoyl, N--(C.sub.1-6 alkyl) carbamoyl and halogen; and any of the foregoing interrupted by oxygen atoms;
and A and any group B may be the same or different and each represents a reactive functional grouping selected from the group consisting of a halogen atom, an aryl halide group, an alkanesulphonyloxy group, an arenesulphonyloxy group, an .alpha.-halomethyl carbonyl group, a carboxyl group, an anhydride group, an optionally sulphonated succinimidyloxy group, a hydroxyl group, a mercapto group, an alkene group, an .alpha., .beta.-alkene ester group, an .alpha., .beta.-alkene amide group, an .alpha., .beta.-alkene ketone group, a conjugated diyne group, a conjugated enyne group, an epoxy group, an amino group, a diazo group, an imidoester group, an alkyl halide group, an aralkyl halide group, a nitroaryl halide group, an aryl azide group, a diazo group, a diazirine group, a formyl group or the dimethyl acetal thereof, an acetyl group, an isocyanate group, an isothiocyanate group, a semicarbazide group, a thiosemicarbazide group, a carboxy (nitro) phenol group, an alkanoyl azide group, a hydrazine group, a haloformate group, an optionally sulphonated maleimide group, a nitrosourea group, an s-triazine group, an aziridine group and a pyridyl disulphide group;
or at least one of A.R.sup.8 -- and any group --R.sup.9.B represents an optionally substituted vinyl group.
2. The method of claim 1 wherein the crosslinking agent is a compound of formula (IIIa) in which R.sup.1 and R.sup.2 are each selected from the group consisting of hydrogen atoms and C.sub.1-4 alkyl groups.
3. The method of claim 1 wherein the crosslinking agent is a compound of formula (IIIa) in which R.sup.8 and any group R.sup.9 are selected from the group consisting of C.sub.1-30 alkylene; C.sub.1-30 alkylene interrupted by one or more oxy, carbonyloxy or oxycarbonyl groups; phenylene; phenyleneoxymethylene and phenyleneethynylmethylene.
4. The method of claim 1 wherein the crosslinking agent is methylene bis(16-hydroxyhexadecanoate).
5. The method of claim 1 wherein the crosslinkable substrate is an ultrasound contrast agent.
6. The method of claim 1 wherein the cross-linking agent is methylene diacrylate.
7. The method of claim 1 wherein the cross-linkable substrate is galactose.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.